2019
DOI: 10.1016/j.chest.2019.03.003
|View full text |Cite
|
Sign up to set email alerts
|

Use of Balloon Atrial Septostomy in Patients With Advanced Pulmonary Arterial Hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
35
0
3

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(38 citation statements)
references
References 24 publications
0
35
0
3
Order By: Relevance
“…Current literature describes BAS as a ''bridging'' therapy for lung transplantation or a palliative therapy to decrease symptomatology and increase short-term survival due to favorable hemodynamic changes. [3][4][5][6][7] BAS does not appear to have ever been performed as a salvage therapy to allow weaning and decannulation from ECMO.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Current literature describes BAS as a ''bridging'' therapy for lung transplantation or a palliative therapy to decrease symptomatology and increase short-term survival due to favorable hemodynamic changes. [3][4][5][6][7] BAS does not appear to have ever been performed as a salvage therapy to allow weaning and decannulation from ECMO.…”
Section: Discussionmentioning
confidence: 99%
“…3 Balloon atrial septostomy (BAS) is a palliative intervention recommended (Class IIb, Level C evidence) in adult patients with PAH awaiting lung transplantation who have failed maximal medical therapy. 3 No recommendations exist on the use of BAS in pediatric patients with severe PAH. Moreover, no literature exists on its use as a palliative therapy to transition off of extracorporeal membrane oxygenation (ECMO) support.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Indications for BAS include syncope, right heart failure, refractory to chronic PAH-targeted therapy, and symptomatic low cardiac output states [ 31 , 32 ]. In the hand of experienced interventionists, it has been a relatively safe procedure with beneficial hemodynamic effect in children and adults with severe PAH [ 33 , 34 , 35 ]. The risk factors associated with high procedural mortality were a mean right atrial pressure > 20 mmHg, resting arterial oxygen saturation < 90%, a left ventricular end-diastolic pressure > 18 mmHg, an indexed pulmonary vascular resistance > 55 Wood units·m 2 and severe right ventricular failure [ 34 , 36 , 37 ].…”
Section: Group 1 Ph ( Table 1 )mentioning
confidence: 99%
“…Indeed, the early unacceptable procedure-related mortality has been significantly reduced due to a better selection of candidates, technical improvements, and growing experience in dedicated centers [ 2 ]. Despite the use and demonstrated short-term hemodynamic benefits of atrial septostomy in a meta-analysis [ 3 ], its long-term safety, efficacy, and therapeutic role in the setting of advanced PAH were not well defined. A relatively frequent outcome of the procedure, the defect’s spontaneous closure, hindered this knowledge [ 2 ].…”
mentioning
confidence: 99%